Shares of Renalytix Plc (LON:RENX – Get Free Report) shot up 3.9% during mid-day trading on Monday . The company traded as high as GBX 7.33 and last traded at GBX 7.10. 489,275 shares changed hands during trading, a decline of 69% from the average session volume of 1,561,954 shares. The stock had previously closed at GBX 6.84.
Renalytix Trading Up 9.7%
The company has a quick ratio of 2.42, a current ratio of 0.24 and a debt-to-equity ratio of -72.91. The company has a market capitalization of £30.40 million, a P/E ratio of -0.47 and a beta of 2.10. The business has a fifty day moving average price of GBX 8.21 and a 200 day moving average price of GBX 7.49.
About Renalytix
Renalytix (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company’s lead product is KidneyIntelX, which has been granted Breakthrough Designation by the U.S.
See Also
- Five stocks we like better than Renalytix
- What is the Euro STOXX 50 Index?
- Battle of the Black Friday Stocks: Amazon vs. Walmart vs. Target
- What Are Dividend Contenders? Investing in Dividend Contenders
- 4 Cold-Weather Stocks to Buy as Winter Spending Heats Up
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Disney Stock Drops—Will Earnings Pave Way for a YouTube TV Truce?
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
